Initial $2.26 Million Award Funds Project That Will Serve as a Unique Resource For Families and Researchers
(New York, New York) -- Autism Speaks, a non-profit organization dedicated to increasing awareness about the growing autism health crisis and raising funds for critical autism research, today announced that its board of directors has voted to fund a program for the development of a national autism database. Kennedy Krieger Institute, one of the nation's leading treatment centers for autism and other developmental disorders, will develop the open, interactive database.
Kennedy Krieger celebrates Autism Awareness Month with a Play Date'
at its Center for Autism and Related Disorders
Baltimore - Recent research at Kennedy Krieger reveals that autism can be diagnosed in children as young as 6 months of age, when interventions have the most successful outcomes. Educating pediatricians, developmental practitioners and parents about the earliest signs of autism, and getting children screened as early as possible, is key to improving outcomes.
Kennedy Krieger Institute one of eight comprehensive research centers in country
Baltimore - Kennedy Krieger Institute was awarded today a five-year, $7.7 million grant from the National Institutes of Health to start up a national center devoted to autism research, focusing on neurobiologic origins of autism, as well as early detection and intervention.
BALTIMORE, MD - Researchers at Kennedy Krieger Institute are leading one of the world's most promising new studies of children with autism, designed to identify the signs of the neurological disorder earlier in a child's life, leading to earlier intervention and improved outcomes. The study coincides with Autism Awareness Month.
Children with Difficulty Communicating Verbally Voice Themselves Through Artistic Expression
BALTIMORE, MD - Students from the Kennedy Krieger Institute's lower and middle schools and LEAP program (for children with autism), will be showcasing over 50 pieces of original artwork in a special show at the Chesapeake Center for Creative Arts from May 18- June 1. The exhibit will consist of drawings, paintings and three-dimensional pieces including kites, masks and painted shoes.
Findings suggest possibility for diagnosis, treatment
BALTIMORE, MD - In a study to be published today in the journal Neurology, researchers at Kennedy Krieger Institute have identified molecular abnormalities in brain samples of individuals with autism using the new technology, microarray analysis.
Findings Published in the New England Journal of Medicine
BALTIMORE, MD - Researchers at Kennedy Krieger Institute/Johns Hopkins Hospital and seven other research facilities around the country have found that one of a newer class of anti-psychotic medications was successful and well-tolerated for the treatment of serious behavioral disturbances associated with autism in children ages 5 to 17. The findings of the eight-week, placebo-controlled, clinical trial were published today in the New England Journal of Medicine.